Iron Polysaccharide.

Ascorbate reduces ferric iron to the ferrous form the gut transporter carries and holds it soluble at duodenal pH. The polysaccharide complex releases iron for that same route.

Copper-containing hephaestin and ceruloplasmin oxidise iron so it can leave the enterocyte and bind transferrin. Absorbed iron stalls without copper.

Zinc and iron compete at shared divalent uptake when dosed together, each lowering the other. Separating them across the day keeps both.

Calcium taken in the same sitting interferes with iron transfer through the enterocyte. A two-hour gap removes most of it.

Manganese travels on DMT1 and transferrin, the same routes iron uses, so the two compete for entry and carriage. High intake of one shifts handling of the other.

Folate supplies one-carbon units for DNA synthesis in dividing red cell precursors while iron supplies heme. Both are needed for normal red cell output.

B12 regenerates the folate cycle those dividing precursors run on, and iron fills the heme. The three work as one line.

ALA synthase needs pyridoxal 5-phosphate to start heme synthesis, the step that puts iron to work. Iron intake depends on that cofactor being present.

Flavin-dependent reductase activity releases iron from ferritin into circulation. Low riboflavin status limits how well supplemental iron is used.

Vitamin A status influences movement of iron out of stores and the erythroid response to it. Iron performs less well when vitamin A is low.

Catechins bind non-heme iron in the lumen into unabsorbed complexes. Taking them together lowers what the iron dose delivers.

Chlorogenic acids and tannins bind iron in the gut and cut absorption. Spacing the dose away from coffee avoids it.

Curcumin chelates iron and lowers its availability when the two are taken together. Separating them keeps the iron usable.

Magnesium oxide neutralises gastric acid and iron dissolves poorly at higher pH. Co-dosing reduces how much iron becomes available.

Phytate from grains and legumes chelates non-heme iron and holds it in a form the intestine does not take up. Phytase hydrolyses phytate to lower inositol phosphates, which bind iron far less tightly. In a polysaccharide iron complex the iron is already carried on a carbohydrate matrix, so the phytate effect applies to the fraction released in the lumen rather than to the intact complex. The interaction is a food-matrix one and is most relevant when the dose is taken with a cereal-based meal.

Inulin is fermented by colonic bacteria to short-chain fatty acids, which acidify the lumen. A lower pH keeps ferric iron more soluble and gives the colonic epithelium more contact with reduced, absorbable iron. This is a mechanistic and animal-weighted line of reasoning rather than a settled human absorption result. Unabsorbed iron also shifts the substrate available to the microbiota, so the pairing moves in both directions.

Short-chain fructooligosaccharides ferment more proximally than long-chain inulin, so the pH drop happens earlier in the colon. That solubilises ferric iron that escaped small-intestinal uptake. The human data are mostly on calcium and magnesium with iron measured as a secondary endpoint. Read it as plausible mechanism, not a demonstrated iron outcome.

Galactooligosaccharides feed bifidobacteria and lower luminal pH, which favours iron solubility. They also shift the composition of the microbes that compete for unabsorbed iron. The endpoint in most of this work is a microbiota or pH marker, not iron status. A marker is not an outcome and it should be read that way here.

Resistant starch reaches the colon intact and is fermented to butyrate and other short-chain fatty acids. Because a polysaccharide iron complex is built on a hydrolysed starch or sugar polymer, part of its own carrier behaves the same way once the iron has dissociated. The pairing therefore overlaps in substrate rather than adding two separate effects. Human iron-status evidence for the combination is not established.

Lactoferrin binds two ferric ions per molecule with very high affinity and stays bound across a wide pH range. Taken with an iron source it can sequester luminal iron and change where and how that iron is presented to the mucosa. Trials have used lactoferrin as a stand-alone iron carrier rather than as an add-on to a polysaccharide complex, so the co-administration picture is inferred from the binding chemistry. The direction of the net effect depends on dose order and timing.

Certain Lactobacillus plantarum strains generate lactic acid and can reduce ferric to ferrous iron in the gut lumen, the oxidation state the DMT1 transporter accepts. Fermented food work has reported higher non-heme iron uptake markers when these strains are present. Strain specificity is the whole story here, so the effect does not carry across the genus. This is mechanistic and strain-level, not a general probiotic claim.

Galloyl groups on tannins form insoluble complexes with non-heme iron in the stomach and upper small intestine, and this is one of the most reproducible dietary inhibitors of iron uptake. Tea, coffee and tannin-rich extracts all carry it. A polysaccharide iron complex shields part of its iron inside the carbohydrate matrix, which is the stated rationale for the form, but any iron released in the lumen remains open to the same binding. Spacing the two apart is the usual formulation answer.

Psyllium forms a viscous gel that slows gastric emptying and traps divalent cations, including iron, inside the gel phase. Less iron reaches the mucosal surface in an absorbable form during the transit window. The effect scales with the fibre dose and with how close in time the two are taken. Separating them by a couple of hours is standard formulation practice.

Quercetin has catechol and 3-hydroxy-4-keto sites that bind iron with meaningful affinity, which is why it behaves as both an antioxidant and an iron chelator in vitro. Co-ingestion can lower the free iron pool available for mucosal uptake. Whether that shifts human iron status has not been settled in trials. The chelation itself is well characterised; the downstream absorption consequence is the uncertain part.

The reduced dihydrolipoate form binds transition metals including iron, which is part of why lipoic acid dampens iron-driven hydroxyl radical formation in cell systems. Taken with an iron source it competes for the same free ion pool. This is chemistry and cell work, not a human absorption result. It matters most as a rationale for spacing rather than as an expected benefit of combining.

N-acetylcysteine donates a thiol that both chelates iron weakly and reduces ferric to ferrous, and reduced iron drives Fenton chemistry more readily. The net direction depends on concentration, so cell work has reported both antioxidant and pro-oxidant behaviour for this pair. Nothing here supports a claimed benefit of taking them together. It is listed because the interaction is real and worth flagging.

Ferric iron needs an acidic environment to stay soluble long enough to be reduced and taken up, which is why gastric acid matters for iron salts. Betaine hydrochloride is used in formulation to lower gastric pH transiently. The premise of a polysaccharide iron complex is that iron stays bound to the polymer and releases gradually, so it depends less on gastric acid than a simple ferrous salt does. The pairing is formulation reasoning, not a tested combination.

Glycine forms a small neutral bis-chelate with iron that can cross the mucosa through routes separate from ionic iron, which is the design of glycinate mineral forms. Free glycine taken alongside a polysaccharide complex does not reproduce a manufactured chelate, since the chelation happens during synthesis, not in the stomach. The relationship is mostly informative about how the sibling forms differ. Read it as chemistry rather than as a stacking recommendation.

Calcium interferes with non-heme iron uptake at the enterocyte, an effect seen with both dietary calcium and calcium supplements and reproducible enough to be a standard dosing caution. Carbonate adds a second issue: it neutralises gastric acid, and acid supports iron solubility. Both mechanisms push the same way. Separating the two doses across the day is the usual answer.

Free iron catalyses lipid peroxidation and alpha-tocopherol terminates the resulting chain reactions in membranes. In a supplement context this is a rationale for pairing rather than a demonstrated human result. No absorption interaction between the two is established. Read it as mechanistic.

Glutathione peroxidases are selenoenzymes that clear hydrogen peroxide, the substrate iron uses in Fenton chemistry. Adequate selenium therefore supports the normal antioxidant handling of an iron-loaded environment. The two do not compete for absorption. The link is enzymatic and indirect rather than an absorption interaction.

Iron that is not absorbed in the small intestine reaches the colon, where it changes which organisms grow. Bifidobacteria have low iron requirements compared with several enteric genera, so supplementing them alongside iron has been examined as a way to steer that shift. The human evidence is early and mostly composition markers. A microbiota marker is not a clinical outcome.

Lysine has been studied as a co-factor for iron uptake in supplementation work, with the proposed mechanism being amino-acid assisted solubilisation. The supporting studies are small and the effect has not been consistently reproduced. Nothing about it is established for the polysaccharide form specifically. It sits at the early end and is listed for completeness.